DK173789D0 - Anvendelsen af tp-receptorantagonister til at modificere virkningen af myofibroblaster - Google Patents

Anvendelsen af tp-receptorantagonister til at modificere virkningen af myofibroblaster

Info

Publication number
DK173789D0
DK173789D0 DK173789A DK173789A DK173789D0 DK 173789 D0 DK173789 D0 DK 173789D0 DK 173789 A DK173789 A DK 173789A DK 173789 A DK173789 A DK 173789A DK 173789 D0 DK173789 D0 DK 173789D0
Authority
DK
Denmark
Prior art keywords
myofibroblasts
modify
effect
receptor antagonists
antagonists
Prior art date
Application number
DK173789A
Other languages
English (en)
Other versions
DK173789A (da
Inventor
Ian Leslie Naylor
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK173789D0 publication Critical patent/DK173789D0/da
Publication of DK173789A publication Critical patent/DK173789A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK173789A 1988-04-12 1989-04-11 Anvendelsen af tp-receptorantagonister til at modificere virkningen af myofibroblaster DK173789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808599A GB8808599D0 (en) 1988-04-12 1988-04-12 Medicaments

Publications (2)

Publication Number Publication Date
DK173789D0 true DK173789D0 (da) 1989-04-11
DK173789A DK173789A (da) 1989-10-13

Family

ID=10635039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK173789A DK173789A (da) 1988-04-12 1989-04-11 Anvendelsen af tp-receptorantagonister til at modificere virkningen af myofibroblaster

Country Status (9)

Country Link
EP (1) EP0337739A3 (da)
JP (1) JPH0228120A (da)
KR (1) KR890015743A (da)
AU (1) AU621598B2 (da)
DK (1) DK173789A (da)
GB (1) GB8808599D0 (da)
IL (1) IL89910A0 (da)
PH (1) PH26019A (da)
ZA (1) ZA892672B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2354708B (en) * 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
WO2006046545A1 (ja) 2004-10-26 2006-05-04 Kyocera Corporation 弾性表面波素子及び通信装置
JP2010516702A (ja) 2007-01-18 2010-05-20 エヴォルヴァ エスアー 置換１，３−ジオキサンのプロドラッグおよびそれらの使用
US20100273824A1 (en) 2007-01-18 2010-10-28 Evolva Sa Substituted 1,3-dioxanes and their uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127406B (en) * 1982-09-16 1986-03-05 Glaxo Group Ltd Piperidinlycyclopentanolheptenoic acid salt

Also Published As

Publication number Publication date
GB8808599D0 (en) 1988-05-11
KR890015743A (ko) 1989-11-25
EP0337739A2 (en) 1989-10-18
JPH0228120A (ja) 1990-01-30
ZA892672B (en) 1990-04-25
EP0337739A3 (en) 1990-10-10
DK173789A (da) 1989-10-13
IL89910A0 (en) 1989-12-15
AU621598B2 (en) 1992-03-19
PH26019A (en) 1992-01-29
AU3275489A (en) 1989-10-19

Similar Documents

Publication Publication Date Title
FI914533A7 (fi) Fibrinogeenireseptoriantagonisteja
FI914535A7 (fi) Uusia fibrinogeenireseptoriantagonisteja
FI901355A7 (fi) Hajua poistava absorbenttirakenteita
DK36491D0 (da) Praeparat til behandling af erektiv dysfunktion
DK385388D0 (da) Anvendelse af 5ht-3-antagonister
DK412489D0 (da) Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren
FI941178A7 (fi) 5-HT4-reseptoriantagonisteja
FI914797A7 (fi) Tyydyttyneitä hydroksialkyylikinoliinihappoja leukotrieeniantagonisteina
MX9101311A (es) Antagonistas receptores de fibrinogeno
FI904522A7 (fi) Laite hiusvärin keskeytymättömään levittämiseen ihmisen hiuksiin
DK190587A (da) Heterocykliske carboxamider med lenkotrienantagonistvirkning
DE3272044D1 (de) 3-benzazepines as alpha-2 antagonists
DK140789A (da) Overfladesamlingsorganer til fremstilling af betonindsproejtningsforskallinger
ATE116980T1 (de) Verbesserungen an leukotrien-antagonieten.
DK281789D0 (da) Fremgangsmaade til fremstilling af riboflavin i form af granulater
DK495089D0 (da) Anvendelse af thromboxan a2-receptor-antagonister til fremstilling af laegemidler
FI951798L (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
DK279782A (da) Fremgangsmaade til fremstilling af polypropylengenstande navnlig injektionssproejter
DK173789A (da) Anvendelsen af tp-receptorantagonister til at modificere virkningen af myofibroblaster
DK103887D0 (da) Let-aabneligt lukke til daase med lapsoem
DK57589A (da) Fremgangsmaade til at foroege rumvaegten af sproejtetoerrede vaskemidler
TR25348A (tr) CISIMLERIN OTOMATIK SEKILDE YERLESTIRILMELERINI SAGLAYAN DüZEN
DK601489D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
FR2637496B1 (fr) Vibromasseur multifonctionnel
DK482587A (da) Apparat til at indikere vaerdien af en variabel

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)